Welcome to our dedicated page for Caci Intl SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CACI International Inc (NYSE: CACI) SEC filings page brings together the company’s official U.S. Securities and Exchange Commission disclosures, offering investors a structured view of how this national security-focused information solutions and services provider reports material events, financing arrangements, governance actions, and strategic transactions. CACI’s filings appear under its registrant name and document its activities as a public company serving primarily U.S. government agencies and departments.
Through this page, readers can access current and historical Forms 8-K in which CACI reports items such as quarterly and annual financial results, amendments to credit agreements, accounts receivable purchase arrangements, incentive compensation plans, and board and committee matters. Recent 8-K filings, for example, describe a Second Amended and Restated Credit Agreement with specified term loan and revolving credit facilities, amendments to a Master Accounts Receivable Purchase Agreement, and shareholder approval of the CACI International Inc 2025 Incentive Compensation Plan.
Filings also capture strategic transactions and acquisition agreements. An 8-K dated December 22, 2025 outlines a Purchase Agreement and Plan of Merger under which a CACI subsidiary agreed to acquire ARKA Group L.P. for an aggregate cash purchase price, subject to customary conditions and regulatory approvals. Related disclosures include information on planned debt financing commitments and bridge loan facilities associated with that transaction.
Investors can use this page to locate quarterly and annual reports (Forms 10-Q and 10-K when available), which provide more detailed discussions of segment operations, risk factors, and financial statements, as well as proxy materials such as the DEF 14A that describe director elections, advisory votes on executive compensation, and auditor ratification. Stock Titan’s platform adds AI-powered summaries to help explain the key points in lengthy filings, highlight important sections, and make it easier to interpret complex topics like leverage covenants, incentive plans, and acquisition structures.
For users analyzing CACI stock, this SEC filings page serves as a centralized resource for understanding how the company documents its national security-oriented business, capital structure, governance, and material events in its official regulatory reports.
CACI International Inc. (CACI): Director Charles L. Szews reported the settlement of 83 shares of CACI common stock on 10/12/2025 via the conversion (Code M) of restricted stock units. Following this transaction, he beneficially owns 331 shares, held directly.
The 83-share vesting represents the final tranche of a 331 RSU grant awarded on 10/17/2024, which vested as 82 shares on 01/15/2025, 83 on 04/15/2025, 83 on 07/14/2025, and 83 on 10/12/2025.
CACI International (CACI): Director Lisa Disbrow reported the vesting and settlement of 83 restricted stock units into CACI common stock on 10/12/2025 (transaction code M). Following this transaction, she beneficially owns 1,934 shares, held directly.
The RSUs were part of a 331‑unit grant made on October 17, 2024, vesting in tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025.
CACI International (CACI): Director Susan M. Gordon reported the settlement of restricted stock units into common shares. On 10/12/2025, 83 RSUs vested and converted into 83 shares of CACI common stock (transaction code M), consistent with a previously disclosed grant.
The RSUs were part of a 331-unit award granted on October 17, 2024, vesting in four tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025. Following this vesting, Ms. Gordon directly owns 2,737 CACI shares.
This filing reflects routine equity compensation vesting for a director and does not indicate an open-market purchase or sale.
Jeffrey D. MacLauchlan, Chief Financial Officer of CACI International Inc. (CACI), reported multiple equity awards and vesting-related transactions dated
John S. Mengucci, President & CEO and director of CACI International, Inc. (CACI), reported multiple stock-based transactions on 10/01/2025 on Form 4. The filing shows a mix of acquisitions and dispositions of common stock and the vesting/granting of restricted stock units (RSUs) and performance RSUs (PRSUs). Following the transactions, Mr. Mengucci beneficially owned between 103,884 and 128,827 shares across the reported lines depending on each transaction line's cumulative totals. The report records vested and newly granted awards: 12,618 PRSUs and 12,617 RSUs granted on 10/01/2025, plus earlier grants from 2022–2024 with specified vesting schedules. Several disposition entries list a price of $515.16 per share. The filing is a routine insider report documenting compensation-related equity grants and related share movements.
DeEtte Gray, President, US Operations of CACI, reported transactions dated 10/01/2025 on a Form 4. The filing shows multiple restricted stock unit and performance restricted stock unit grants and vesting events: prior grants from 10/01/2022, 10/01/2023, and 10/01/2024 are described, and new grants on 10/01/2025 include 2,233 performance RSUs and 2,232 restricted stock units. The Form 4 also records a series of non-derivative transactions on the same date including dispositions executed at a reported price of $515.16. The tables list changing beneficial ownership totals after each reported event for CACI common stock. The signature date on the form is 10/03/2025.
Tracy Weir, Chief Executive Officer, UK of CACI International Inc. (CACI), reported multiple transactions dated 10/01/2025. The Form 4 shows grants of 291 restricted stock units and 292 performance restricted stock units (total 583 units) granted on that date; the PRSUs vest on the third anniversary subject to a three‑year performance measure and the RSUs vest one‑third per year over three years. The filing also records multiple dispositions totaling 413 shares sold at $515.16 per share, and changes in beneficial ownership levels reported after each transaction. The report is a routine insider filing documenting equity awards and share sales by an executive.
J. William Koegel Jr., EVP & General Counsel of CACI (CACI) reported multiple transactions dated 10/01/2025. The filing shows the vesting/acquisition of 4,442 common shares through restricted stock units and performance restricted stock units and the grant of 971 additional restricted stock units plus 971 performance restricted stock units. Concurrently, the report discloses dispositions of 2,101 common shares at $515.16 per share. After these transactions, Mr. Koegel beneficially owned 27,931 shares of CACI common stock, held directly.
Eric Blazer, Senior Vice President, Corporate Controller & Chief Accounting Officer of CACI International, Inc. (CACI), reported equity awards and transactions on a Form 4. On 10/01/2025 he received 194 restricted stock units (RSUs) and 195 performance restricted stock units (PRSUs); the PRSUs vest on the third anniversary based on a three‑year performance measure. The report also records earlier entries: a 65-share grant coded as M and an earlier 198 RSU grant dated 10/01/2024 that vests one‑third per year for three years. Following the transactions reported, Mr. Blazer beneficially owns reported totals of 132, 112, and derivative holdings of 194, 195, and 133 shares in the classes listed. The Form is signed 10/03/2025.
Insider sale by CEO and director John S. Mengucci: The Form 4 shows Mr. Mengucci sold 10,175 shares of CACI common stock on 09/15/2025 in multiple transactions at weighted-average prices ranging roughly from $490.29 to $493.96 per share. After these disposals his reported beneficial ownership declined from 111,678 shares to 101,536 shares.
The filing lists Mr. Mengucci as both President & CEO and a director and provides transaction-level price ranges for each grouped sale. No derivative transactions or other compensatory grants are reported in this Form 4. The form is signed by the reporting person on 09/16/2025.
FAQ
What is the current stock price of Caci Intl (CACI)?
What is the market cap of Caci Intl (CACI)?
